Advances in Pediatric and Adult Cochlear Implant and Middle Ear Prostheses

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Otolaryngology".

Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 6340

Special Issue Editors


E-Mail Website
Guest Editor
Clinic of Audiology & ENT, University of Ferrara, Ferrara, Italy
Interests: hearing science; auditory processing; teleaudiology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Associate Guest Editor
Clinic of Audiology & ENT, University of Ferrara, Ferrara, Italy
Interests: hearing aids; cochlear implants; hearing loss; tinnitus; vertigo
Special Issues, Collections and Topics in MDPI journals

E-Mail
Associate Guest Editor
Department of Teleaudiology and Screening, World Hearing Center, Institute of Physiology and Pathology of Hearing, 10 Mochnackiego Street, 02-042 Warsaw, Poland
Interests: cochlear implants; middle ear prostheses; hearing aids; teleaudiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Cochlear implantation and middle ear prosthetic technologies have been developed during the last 20 years and have been implemented in numerous clinical settings around the world. Nevertheless, as technology progresses, more questions arise about the quality of the technological intervention strategies, about the efficiency and critical timing of programmed intervention (hearing aids, cochlear implants), and about the costs of traditional and alternative intervention policies.

The objective of this Special Issue is to share with the scientific community the latest trends in the cochlear implants field and related technological advances. We invite authors to send papers describing recent developments in (but not limited to) the following potential topics:

  • Ear Implantable Devices
  •  Middle ear
    • Piezoelectric (i.e., envoy);
    • Electromagnetic (vibrant soundbridge; otologics carina);
    • Bone conduction implants, percutaneous vs. transcutaneous (i.e BAHA, Oticon Ponto);
  • Inner ear
    • Cochlear implants;
    • Cochlear implants with intracochlear drug delivery;
    • Cochlear implants in inner ear malformations;
    • Cochlear implants in the single side deafness;
    • Cochlear implants and vestibular function;
    • Hybrid cochlear implants;
    • Factors which could affect hearing preservation in cochlear implants;
    • Ecog in cochlear implantation;
    • Cochlear implantation after radical modified surgery.

Dr. Stavros Hatzopoulos
Dr. Andrea Ciorba
Dr. Piotr H. Skarżyński
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Cochlear implants
  • Implantable hearing aids
  • Drug delivery
  • Hearing preservation
  • Electrophysiology
  • Middle ear implantable technologies
  • Vestibular function
  • Unilateral cochlear implantation
  • Bilateral cochlear implantation
  • Age limits in cochlear implantation

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research

3 pages, 174 KiB  
Editorial
Advances in Pediatric and Adult Cochlear Implant and Middle Ear Prostheses
by Andrea Ciorba, Piotr H. Skarżyński, Hulya Gocmenler and Stavros Hatzopoulos
J. Clin. Med. 2021, 10(14), 3152; https://doi.org/10.3390/jcm10143152 - 16 Jul 2021
Viewed by 1878
Abstract
The aim of this special issue, entitled ‘Advances in Pediatric and Adult Cochlear Implant and Middle Ear Prostheses’, is to report the undergoing novel research in the area of ear prostheses, either for the middle or inner ear [...] Full article

Research

Jump to: Editorial

18 pages, 4709 KiB  
Article
The Spatial Selective Auditory Attention of Cochlear Implant Users in Different Conversational Sound Levels
by Sara Akbarzadeh, Sungmin Lee and Chin-Tuan Tan
J. Clin. Med. 2021, 10(14), 3078; https://doi.org/10.3390/jcm10143078 - 12 Jul 2021
Viewed by 1853
Abstract
In multi-speaker environments, cochlear implant (CI) users may attend to a target sound source in a different manner from normal hearing (NH) individuals during a conversation. This study attempted to investigate the effect of conversational sound levels on the mechanisms adopted by CI [...] Read more.
In multi-speaker environments, cochlear implant (CI) users may attend to a target sound source in a different manner from normal hearing (NH) individuals during a conversation. This study attempted to investigate the effect of conversational sound levels on the mechanisms adopted by CI and NH listeners in selective auditory attention and how it affects their daily conversation. Nine CI users (five bilateral, three unilateral, and one bimodal) and eight NH listeners participated in this study. The behavioral speech recognition scores were collected using a matrix sentences test, and neural tracking to speech envelope was recorded using electroencephalography (EEG). Speech stimuli were presented at three different levels (75, 65, and 55 dB SPL) in the presence of two maskers from three spatially separated speakers. Different combinations of assisted/impaired hearing modes were evaluated for CI users, and the outcomes were analyzed in three categories: electric hearing only, acoustic hearing only, and electric + acoustic hearing. Our results showed that increasing the conversational sound level degraded the selective auditory attention in electrical hearing. On the other hand, increasing the sound level improved the selective auditory attention for the acoustic hearing group. In the NH listeners, however, increasing the sound level did not cause a significant change in the auditory attention. Our result implies that the effect of the sound level on selective auditory attention varies depending on the hearing modes, and the loudness control is necessary for the ease of attending to the conversation by CI users. Full article
Show Figures

Figure 1

13 pages, 2289 KiB  
Article
The Clinical Effects of Steroids Therapy in the Preserving Residual Hearing after Cochlear Implantation with the OTICON Neuro Zti EVO
by Magdalena B. Skarzynska, Aleksandra Kolodziejak, Elżbieta Gos and Piotr H. Skarzynski
J. Clin. Med. 2021, 10(13), 2868; https://doi.org/10.3390/jcm10132868 - 28 Jun 2021
Cited by 10 | Viewed by 1863
Abstract
Background: A prospective clinical study was conducted to investigate whether two different pharmacotherapy strategies of steroid administration impact hearing preservation in adult patients who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. Methods: Twenty nine adult participants were included. Pure [...] Read more.
Background: A prospective clinical study was conducted to investigate whether two different pharmacotherapy strategies of steroid administration impact hearing preservation in adult patients who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. Methods: Twenty nine adult participants were included. Pure tone audiometry was performed before implantation, during processor activation and 12 months after activation. There were three treatment groups: (1) intravenous steroid therapy (standard steroid therapy with dexamethasone administrated intravenously at the dose 0.1 mg/kg body mass twice a day); (2) combined oral and intravenous steroid therapy (extended steroid therapy with dexamethasone administrated intravenously at the dose 0.1 mg/kg b.m. twice a day and prednisone (orally) at the dose 1 mg/kg body mass/24 h), and (3) no steroid therapy (a control group). Patients’ hearing thresholds before implantation were on average 103 dB HL, 89 dB HL, and 93 dB HL, respectively. Results: Deterioration of hearing thresholds was observed in all three patients’ groups. Twelve months after surgery the patients with and without steroid therapy had similar hearing thresholds. Conclusions: The steroid regimen used in this study did not play a significant role in patients with non-functional residual hearing, who underwent cochlear implantation with the Oticon Medical Neuro cochlear implant system. Full article
Show Figures

Figure 1

Back to TopTop